AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32826639 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise with 60% BSA coverage
Number of subjects: 10
Study 32826639 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise with 40% BSA coverage
Number of subjects: 10
Study 32826639 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity exercise with 0% BSA coverage
Number of subjects: 10
Study 32826639 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (0%, 20%, 40%, 60% BSA coverage)
Number of subjects: 10
Study 32756091 — intervention group
Group type: EXPERIMENTAL
Intervention: Liuwei Dihuang pills (LDP)
Number of subjects: 124
Study 32756091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 34820771 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/day rosuvastatin for 6 months
Number of subjects: 35
Study 34820771 — intervention group
Group type: COMPARATOR
Intervention: Usual care for 6 months
Number of subjects: 35
Study 32644844 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-lncRNA signature
Number of subjects: 341
Study 32644844 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram incorporating lncRNA signature and clinical factors
Number of subjects: 341
Study 32644844 — intervention group
Group type: EXPERIMENTAL
Intervention: lncRNA signature
Number of subjects: 341
Study 32644844 — intervention group
Group type: EXPERIMENTAL
Intervention: GSEA analysis
Number of subjects: 341
Study 35954698 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric training (Handgrip Jamar®)
Number of subjects: 15
Study 35954698 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilatory muscle training (PowerBreathe®)
Number of subjects: 15
Study 35954698 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional respiratory and motor physiotherapy)
Number of subjects: 15
Study 33382407 — intervention group
Group type: EXPERIMENTAL
Intervention: SQLNS (small‐quantity lipid‐based nutrient supplementation)
Number of subjects: 48
Study 33382407 — intervention group
Group type: COMPARATOR
Intervention: Control (no SQLNS)
Number of subjects: 48
Study 32741829 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Playlist Guide
Number of subjects: 45
Study 32741829 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control Group
Number of subjects: 45
Study 35895987 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile flow (group P)
Number of subjects: 12
Study 35895987 — intervention group
Group type: COMPARATOR
Intervention: Nonpulsatile flow (group NP)
Number of subjects: 12
Study 32875388 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymyxin B (PB) 50 IU, q12h
Number of subjects: 42
Study 33478205 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 160
Study 33478205 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 160
Study 34022697 — intervention group
Group type: EXPERIMENTAL
Intervention: TPC-ICT (docetaxel, cisplatin, cetuximab)
Number of subjects: 100
Study 34022697 — intervention group
Group type: COMPARATOR
Intervention: TPF-ICT (docetaxel, cisplatin, 5-FU)
Number of subjects: 100
Study 34022697 — intervention group
Group type: EXPERIMENTAL
Intervention: TPC-ICT
Number of subjects: 100
Study 34022697 — intervention group
Group type: COMPARATOR
Intervention: TPF-ICT
Number of subjects: 100
Study 34022697 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TPC and TPF arms
Number of subjects: 100
Study 32373917 — intervention group
Group type: EXPERIMENTAL
Intervention: Arabic decision aid with usual care
Number of subjects: 92
Study 32373917 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 92
Study 36272926 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy combined with nutritional supplementation (Ex + Nutr; n = 29)
Number of subjects: 58
Study 36272926 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy alone (Ex; n = 29)
Number of subjects: 58
Study 33899934 — intervention group
Group type: EXPERIMENTAL
Intervention: Various dosing regimen optimization strategies for ADCs including body weight cap dosing, treatment duration capping, dose schedule adjustments, response-guided dosing recommendations, and randomized dose-finding.
Number of subjects: 0
Study 34558152 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care training program using smartphones (21 sessions, virtual)
Number of subjects: 54
Study 34558152 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 54
Study 32488891 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin-A (BTX-A) injection and a home-based exercise program
Number of subjects: 33
Study 32488891 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercise program
Number of subjects: 33
Study 36002073 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized educational session with a reminder bottle
Number of subjects: 200
Study 36002073 — intervention group
Group type: COMPARATOR
Intervention: Control session on general eye health
Number of subjects: 200
Study 34167656 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (5 daily sessions, 1mA for 20min over parieto-occipital regions)
Number of subjects: 27
Study 34167656 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 27
Study 32412417 — intervention group
Group type: EXPERIMENTAL
Intervention: Smarter Pregnancy program (intervention group)
Number of subjects: 218
Study 32412417 — intervention group
Group type: COMPARATOR
Intervention: Control group (no coaching)
Number of subjects: 218
Study 34612012 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized exercise and nutrition based programme (experimental arm)
Number of subjects: 45
Study 34612012 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control arm)
Number of subjects: 45
Study 32144418 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Adaptation Training (CAT)
Number of subjects: 89
Study 32144418 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 89
Study 34508600 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose (20 g)
Number of subjects: 10
Study 34508600 — intervention group
Group type: COMPARATOR
Intervention: Water intake (control)
Number of subjects: 10
Study 33933751 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fish oil (IV-FO)
Number of subjects: 477
Study 33933751 — intervention group
Group type: COMPARATOR
Intervention: Control group (CNTR)
Number of subjects: 477
Study 34321377 — intervention group
Group type: EXPERIMENTAL
Intervention: LVA ablation (group B)
Number of subjects: 402
Study 34321377 — intervention group
Group type: EXPERIMENTAL
Intervention: LVA without ablation (group C)
Number of subjects: 402
Study 34321377 — intervention group
Group type: COMPARATOR
Intervention: No LVA (group A)
Number of subjects: 402
Study 34321377 — intervention group
Group type: COMPARATOR
Intervention: Incomplete voltage map (group D)
Number of subjects: 402
Study 34321377 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with LVAs (group B+C)
Number of subjects: 402
Study 34321377 — intervention group
Group type: COMPARATOR
Intervention: Patients without LVAs (group A)
Number of subjects: 402
Study 32772873 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal ketamine (50 mg)
Number of subjects: 100
Study 32772873 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl alone (control)
Number of subjects: 100
Study 32772873 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up study
Number of subjects: 100
Study 34701230 — intervention group
Group type: EXPERIMENTAL
Intervention: SABR (Stereotactic Ablative Radiotherapy)
Number of subjects: 0
Study 34701230 — intervention group
Group type: EXPERIMENTAL
Intervention: SABR
Number of subjects: 0
Study 32585077 — intervention group
Group type: EXPERIMENTAL
Intervention: Differentiated service delivery (DSD) model implementation including repeat prescription collection strategies (RPCS)
Number of subjects: 88
Study 32585077 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced counselling and tracing patients lost-to-follow-up for patients not stable on treatment
Number of subjects: 88
Study 32585077 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling for new HIV patients
Number of subjects: 88
Study 32585077 — intervention group
Group type: EXPERIMENTAL
Intervention: Training for providers on DSD model
Number of subjects: 88
Study 32585077 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to data for providers
Number of subjects: 88
Study 32585077 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall implementation of DSD models
Number of subjects: 88
Study 34738278 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthesia + LLLT (diode laser: 810 nm; continuous mode; 0.3W; 20 s; 69 J/cm2)
Number of subjects: 60
Study 34738278 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthesia + LLLT
Number of subjects: 60
Study 34738278 — intervention group
Group type: COMPARATOR
Intervention: Topical anesthesia
Number of subjects: 60
Study 33373935 — intervention group
Group type: COMPARATOR
Intervention: Control diet meeting NRC (2007) requirements (CON)
Number of subjects: 32
Study 33373935 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 10% higher ME using corn grain (HEC)
Number of subjects: 32
Study 33373935 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 10% higher ME using flaxseed (HEF)
Number of subjects: 32
Study 33373935 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 10% higher MP using rumen-protected lysine and methionine (PRO)
Number of subjects: 32
Study 33373935 — intervention group
Group type: COMPARATOR
Intervention: Control diet (CON)
Number of subjects: 32
Study 33373935 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately over-fed ewes with MP and ME
Number of subjects: 32
Study 33076294 — intervention group
Group type: EXPERIMENTAL
Intervention: Low plasma total cysteine (tCys) (≤25th percentile)
Number of subjects: 2102
Study 33076294 — intervention group
Group type: COMPARATOR
Intervention: Plasma total cysteine (tCys) >25th percentile
Number of subjects: 2102
Study 35124321 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 7213
Study 35124321 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 7213
Study 33481085 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical frequency domain imaging (OFDI)
Number of subjects: 20
Study 32840930 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril–valsartan
Number of subjects: 4795
Study 32840930 — intervention group
Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 4795
Study 32840930 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperuricaemia
Number of subjects: 4795
Study 35043553 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine acellular dermal matrix (pADM)
Number of subjects: 20
Study 35043553 — intervention group
Group type: COMPARATOR
Intervention: Autogenous connective tissue graft (CTG)
Number of subjects: 20
Study 36495162 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexcom G4 CGM sensor
Number of subjects: 172
Study 36495162 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbott Libre Pro CGM sensor
Number of subjects: 172
Study 34432983 — intervention group
Group type: EXPERIMENTAL
Intervention: Mainstream American English recordings
Number of subjects: 73
Study 34432983 — intervention group
Group type: COMPARATOR
Intervention: AAE recordings
Number of subjects: 73
Study 35905275 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine digluconate mouth rinse
Number of subjects: 0
Study 35905275 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine digluconate lozenges
Number of subjects: 0
Study 35905275 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone iodine mouth rinse
Number of subjects: 0
Study 35905275 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 0
Study 33477165 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology applied for 20 min (10 min for each foot) twice a day with 8-hour intervals on the first and second days after CS
Number of subjects: 60
Study 33477165 — intervention group
Group type: COMPARATOR
Intervention: Control group received routine nursing care for approximately 3 hours after CS
Number of subjects: 60
Study 33477165 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology intervention
Number of subjects: 60
Study 32756124 — intervention group
Group type: EXPERIMENTAL
Intervention: Microendoscopic discectomy
Number of subjects: 0
Study 32756124 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 0
Study 33829300 — intervention group
Group type: EXPERIMENTAL
Intervention: Open release
Number of subjects: 80
Study 33829300 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic release
Number of subjects: 80
Study 32588746 — intervention group
Group type: EXPERIMENTAL
Intervention: Early feeding group (soft food diet served at Postoperative Hour 2)
Number of subjects: 262
Study 32588746 — intervention group
Group type: COMPARATOR
Intervention: On-demand feeding group (eating whenever they wanted to upon return to the ward)
Number of subjects: 262
Study 32588746 — intervention group
Group type: EXPERIMENTAL
Intervention: Early feeding group
Number of subjects: 262
Study 32588746 — intervention group
Group type: COMPARATOR
Intervention: On-demand feeding group
Number of subjects: 262
Study 32054484 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination with evidence (BCG, DPT-Hi+Hb 3, Measles/Rubella) in children aged 12-23 months
Number of subjects: 1430
Study 32054484 — intervention group
Group type: EXPERIMENTAL
Intervention: Missed vaccination appointments for BCG and Measles/Rubella
Number of subjects: 1430
Study 32054484 — intervention group
Group type: EXPERIMENTAL
Intervention: Dropout rates for vaccinations in children aged 12-23 months
Number of subjects: 1430
Study 33835715 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin trough concentration (VTC) less than 10 mg/L
Number of subjects: 7220
Study 33835715 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin trough concentration (VTC) 10–15 mg/L
Number of subjects: 7220
Study 33835715 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin trough concentration (VTC) 15–20 mg/L
Number of subjects: 7220
Study 33835715 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin trough concentration (VTC) greater than 20 mg/L
Number of subjects: 7220
Study 33030868 — intervention group
Group type: EXPERIMENTAL
Intervention: eLearning module on prepubertal bleeding
Number of subjects: 97
Study 33030868 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 97
Study 97266229 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin administration during hyperglycaemic conditions
Number of subjects: 6
Study 97266229 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin administration during normoglycaemic conditions
Number of subjects: 6
Study 97266229 — intervention group
Group type: COMPARATOR
Intervention: Insulin administration in normal subjects
Number of subjects: 6
Study 36332161 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab for 15 months
Number of subjects: 927
Study 36332161 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab for 30 months
Number of subjects: 927
Study 34455940 — intervention group
Group type: EXPERIMENTAL
Intervention: Multispecies probiotics
Number of subjects: 584
Study 35791476 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic (KWAI) 300 mg daily in doses of 0.3g, 0.6g, 0.9g, 1.2g, and 1.5g for 24 weeks
Number of subjects: 0
Study 35791476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35791476 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin (standard lipid-lowering agent)
Number of subjects: 0
Study 33895619 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative digital subtraction angiography (ioDSA)
Number of subjects: 54
Study 33895619 — intervention group
Group type: COMPARATOR
Intervention: Indocyanine green (ICG) angiography
Number of subjects: 54
Study 32166877 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin alongside seasonal malaria chemoprevention (sulfadoxine–pyrimethamine plus amodiaquine)
Number of subjects: 19578
Study 32166877 — intervention group
Group type: COMPARATOR
Intervention: Placebo alongside seasonal malaria chemoprevention (sulfadoxine–pyrimethamine plus amodiaquine)
Number of subjects: 19578
Study 35333803 — intervention group
Group type: EXPERIMENTAL
Intervention: Anal bulking agent with polyacrylate‐polyalcohol copolymer particles
Number of subjects: 0
Study 35333803 — intervention group
Group type: COMPARATOR
Intervention: Endoanal electrical stimulation with biofeedback
Number of subjects: 0
Study 35333803 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life evaluation
Number of subjects: 0
Study 33452662 — intervention group
Group type: EXPERIMENTAL
Intervention: Resuscitation preference conversations conducted by trained nurses in group I (n = 165)
Number of subjects: 329
Study 33452662 — intervention group
Group type: COMPARATOR
Intervention: Resuscitation preference conversations conducted by trained nurses in group II (n = 164)
Number of subjects: 329
Study 33452662 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with discordance
Number of subjects: 329
Study 32448336 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous buprenorphine (0.02 mg/kg)
Number of subjects: 24
Study 32448336 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular buprenorphine (0.02 mg/kg)
Number of subjects: 24
Study 32448336 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous buprenorphine (0.02 mg/kg)
Number of subjects: 24
Study 32448336 — intervention group
Group type: COMPARATOR
Intervention: Carprofen (4.4 mg/kg SC)
Number of subjects: 24
Study 34346091 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation (multi-nutrient, protein-rich formula)
Number of subjects: 160
Study 34346091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 34453013 — intervention group
Group type: COMPARATOR
Intervention: CHO (Carbohydrate drink 1.2 g kg‐1 2 hr‐1)
Number of subjects: 12
Study 34453013 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO + PRO (Carbohydrate drink with whey protein concentrate 0.3 g kg‐1 2 hr‐1)
Number of subjects: 12
Study 34453013 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO + PROH (Carbohydrate drink with whey protein hydrolysate 0.3 g kg‐1 2 hr‐1)
Number of subjects: 12
Study 34453013 — intervention group
Group type: COMPARATOR
Intervention: CHO
Number of subjects: 12
Study 34453013 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO + PRO
Number of subjects: 12
Study 34453013 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO + PROH
Number of subjects: 12
Study 36170317 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone
Number of subjects: 30
Study 36170317 — intervention group
Group type: EXPERIMENTAL
Intervention: PRGF + autologous bone
Number of subjects: 30
Study 36170317 — intervention group
Group type: COMPARATOR
Intervention: Control (spontaneous healing)
Number of subjects: 30
Study 36170317 — intervention group
Group type: EXPERIMENTAL
Intervention: PRGF + DFDBA
Number of subjects: 30
Study 36170317 — intervention group
Group type: EXPERIMENTAL
Intervention: PRGF
Number of subjects: 30
Study 34656170 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + PBM (EAP)
Number of subjects: 36
Study 34656170 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + Sham PBM (ESP)
Number of subjects: 36
Study 34656170 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 36
Study 32233173 — intervention group
Group type: EXPERIMENTAL
Intervention: Air purifier filter (filter-on condition)
Number of subjects: 30
Study 32233173 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo (filter-off condition)
Number of subjects: 30
Study 33549072 — intervention group
Group type: EXPERIMENTAL
Intervention: ShootSafe (interactive educational website)
Number of subjects: 162
Study 33549072 — intervention group
Group type: COMPARATOR
Intervention: Active control website
Number of subjects: 162
Study 32620104 — intervention group
Group type: EXPERIMENTAL
Intervention: Melissa officinalis (2 g)
Number of subjects: 45
Study 32620104 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavandula angustifolia (2 g)
Number of subjects: 45
Study 32620104 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (20 mg)
Number of subjects: 45
Study 36347730 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (LB) plus plain bupivacaine (PB)
Number of subjects: 60
Study 36347730 — intervention group
Group type: COMPARATOR
Intervention: Plain bupivacaine (PB)
Number of subjects: 60
Study 34424165 — intervention group
Group type: EXPERIMENTAL
Intervention: Ring Screening (RS) with niclosamide treatment
Number of subjects: 23
Study 34424165 — intervention group
Group type: EXPERIMENTAL
Intervention: Ring Treatment (RT) with presumptive niclosamide treatment
Number of subjects: 23
Study 34424165 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass Treatment (MT) with niclosamide treatment every 6 months
Number of subjects: 23
Study 36178956 — intervention group
Group type: COMPARATOR
Intervention: Long-axis in-plane approach
Number of subjects: 110
Study 34836009 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased fruit and vegetable intake (FV)
Number of subjects: 66
Study 34836009 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 66
Study 32202035 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposed wound (n=165)
Number of subjects: 331
Study 32202035 — intervention group
Group type: COMPARATOR
Intervention: Dressed wound (n=166)
Number of subjects: 331
Study 36107229 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron (ferric derisomaltose)
Number of subjects: 201
Study 36107229 — intervention group
Group type: COMPARATOR
Intervention: Oral iron (ferrous fumarate)
Number of subjects: 201
Study 33622069 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified bedside post‐pyloric feeding tube placement (M group)
Number of subjects: 63
Study 33622069 — intervention group
Group type: COMPARATOR
Intervention: Conventional Corpak protocol (C group)
Number of subjects: 63
Study 33622069 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard electromagnetic‐guided tube placement (EM group)
Number of subjects: 63
Study 32912462 — intervention group
Group type: EXPERIMENTAL
Intervention: UFR-guided hydration (hydration controlled by the RenalGuard System to reach UFR ≥300 ml/h)
Number of subjects: 702